financetom
Business
financetom
/
Business
/
Gig workers move SC alleging violation of rights to social security by Ola, Uber, Zomato, Swiggy
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Gig workers move SC alleging violation of rights to social security by Ola, Uber, Zomato, Swiggy
Sep 22, 2021 8:25 AM

The trade union of ‘gig workers’ has moved the Supreme Court alleging violation of fundamental ‘Rights to Social Security’ by Ola, Uber, Zomato and Swiggy.

The Indian Federation of App-based Transport Workers (IFAT), which comprises mobileapp-based transport workers and delivery workers across India, has moved the apex court against four platforms - Ola, Uber, Zomato, and Swiggy.

They are alleging that the way these partnership agreements are structured, it leads to exploitation through forced labour.

These workers say that they have a fundamental Right to Social Security and the structure of these arrangements that these partner drivers have with the companies is exploitative and is violative of the fundamental rights.

They point out that whatever term and terminology is used by these platforms, there is no denying the fact that there is an employer-employee relationship between these drivers, gig workers and the platforms and that needs recognition.

The union say that these gig workers should be recognised as workers under the Unorganised Workers Social Security Act, which would help them avail of benefits under various government schemes.

Watch the accompanying video of CNBC-TV18’s Ashmit Kumar for more details.

First Published:Sept 22, 2021 5:25 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CVS Health Will Invest $20 Billion To Simplify US Health System, Delivers Strong Q2 Despite Legal Setbacks
CVS Health Will Invest $20 Billion To Simplify US Health System, Delivers Strong Q2 Despite Legal Setbacks
Jul 31, 2025
CVS Health Corp ( CVS ) stock is trading higher on Thursday after the company reported better-than-expected Q2 earnings and raised its annual guidance. The company reported second-quarter sales of $98.90 billion on Thursday, beating the consensus of $94.85 billion. Total revenues increased 8.4% year over year, driven by revenue growth across all segments. Adjusted earnings of $1.81 per share also beat...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Norwegian Cruise Line Sees Record Advance Ticket Sales, Reaffirms Profit Outlook
Norwegian Cruise Line Sees Record Advance Ticket Sales, Reaffirms Profit Outlook
Jul 31, 2025
Norwegian Cruise Line Holdings Ltd. ( NCLH ) on Thursday reported mixed results for its second quarter. Strong consumer demand continued to drive performance, largely meeting adjusted earnings expectations. The company also reaffirmed its full-year 2025 financial guidance. The cruise operator reported record revenue of $2.52 billion for the quarter, a 6% increase year-over-year (YoY), which missed the average analyst...
AbbVie Lifts Full-Year Guidance as Immunology Drugs Drive Quarterly Beat
AbbVie Lifts Full-Year Guidance as Immunology Drugs Drive Quarterly Beat
Jul 31, 2025
10:28 AM EDT, 07/31/2025 (MT Newswires) -- AbbVie ( ABBV ) raised its full-year outlook on Thursday as the biopharmaceutical company recorded second-quarter results above market expectations, driven by strong revenue growth from its Skyrizi and Rinvoq immunology drugs. Per-share adjusted earnings are now set to come in between $11.88 and $12.08 for 2025, up from its previous guidance of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved